Neoadjuvant systemic treatment strategies have improved outcomes in several solid tumour types. This success has not yet been replicated in renal cell carcinoma (RCC). A consensus and international collaboration are urgently needed for the development of adaptive perioperative immunotherapy strategies for patients with RCC at high risk of recurrence.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eururo.2025.01.007 | DOI Listing |
Publication Analysis
Top Keywords
call neoadjuvant
4
neoadjuvant kidney
4
kidney cancer
4
cancer consortium
4
consortium lessons
4
lessons learned
4
learned cancer
4
cancer types
4
types neoadjuvant
4
neoadjuvant systemic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!